JPMorgan Chase & Co. 13D and 13G filings for LB Pharmaceuticals Inc Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-16 4:01 pm Purchase | 2026-06-30 | 13G | LB PHARMACEUTICALS INC LBRX | JPMORGAN CHASE & CO JPM | 1,497,293 5.200% | 69,725 (+4.88%) | Filing |
| 2026-05-13 10:53 am Sale | 2026-03-31 | 13G | LB PHARMACEUTICALS INC LBRX | JPMORGAN CHASE & CO JPM | 1,427,568 4.900% | -183,914 (-11.41%) | Filing |
| 2026-01-21 08:13 am Purchase | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | JPMORGAN CHASE & CO JPM | 1,611,482 6.300% | 1,611,482 (New Position) | Filing |